Develops redosable gene therapies for serious rare diseases. Now — the numbers.
This is an established company with proven profits.
If every debt were paid off today, $818.5M would still be left in the vault — a solid cushion for hard times.
The market pays 49.9× for every dollar this company earns in a year — a price that already assumes things go well.
Against companies in its own sector, it looks cheaper than 38% of them.
Analysts' average target sits 11% above today's price.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
Debt is low and cash is strong; the finances stand solid.
Clearly below the class average.
This grade is a blend: the profit side is strong, the sales tempo slow.
The stock has been running stronger than the market lately.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
The stock trades below its recent peak — about 8% off the top. A pullback, not a collapse.
The net profit margin is 53% — that slice of every sale is the company’s cushion in hard quarters.
There is $827.8M in the vault; even if every debt were paid off, $818.5M would remain.
It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.
The company’s market value is 50 times its annual profit. Even a small disappointment could hit the price hard.
Over the last 12 months, executives reported 169 sells against just 23 buys. Not an alarm bell by itself, but a number worth watching.
On our five-subject report card, KRYS sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: KRYS is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.
Not covered, because the filings we hold do not carry it: the revenue breakdown.